Related Experiment Video
Updated: Jul 19, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
Infection in the neutropenic and stem cell transplant patient
1Service de Médecine et Laboratoire d'Investigations Cliniques H.J. Tagnon, Institut Jules Bordet Centre des Tumeurs de l'Université Libre de Bruxelles, Rue Héger-Bordet 1, 1000 Brussels, Belgium. 106443.366@compuserve.com
Abstract:
The spectrum of infectious complications in neutropenic patients after stem cell or bone marrow transplant is not very different from that seen in other neutropenic patients, with the possible exception of fungal infections. The prevention and therapy of these infections remain a major challenge. The management of neutropenic patients after stem cell or bone marrow transplant has markedly benefited from the development of new antiviral agents and the use of granulocyte/macrophage colony stimulating factors.
Insights
Infectious complications after stem cell or bone marrow transplant are similar to other neutropenic patients, except for fungal infections. New antiviral agents and colony-stimulating factors improve management of these critical infections.
Area of Science:
- Hematology
- Infectious Diseases
- Transplantation Medicine
Background:
- Neutropenic patients undergoing stem cell or bone marrow transplant face significant risks of infectious complications.
- Fungal infections may be a notable exception in the spectrum of infections observed in this population.
- Managing these infections presents a persistent clinical challenge.
Purpose of the Study:
- To summarize the spectrum of infectious complications in neutropenic patients post-transplant.
- To highlight the challenges in preventing and treating these infections.
- To acknowledge advancements in the management of neutropenic patients.
Main Methods:
- Review of infectious complication patterns in neutropenic patients.
- Analysis of challenges in infection prevention and therapy.
- Evaluation of therapeutic advancements.
Main Results:
- The range of infections in neutropenic transplant recipients largely mirrors that in other neutropenic individuals.
- Fungal infections represent a potential area of divergence.
- Significant progress has been made in managing these patients.
Conclusions:
- Infectious complications post-transplant are a critical concern, with fungal infections requiring specific attention.
- Advances in antiviral therapies and growth factors have improved patient outcomes.
- Continued vigilance and therapeutic innovation are essential for neutropenic transplant patients.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant III: Nursing Management
Cryptococcal Meningitis
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
